Background and Purpose: Non-arteritic branch/central retinal artery occlusions (BRAO/CRAO) and amaurosis fugax (AF) are predominantly caused by embolism. Additionally, transported embolic material could cause ischemic stroke. The aim of the study was to investigate the prevalence, pattern and underlying cause of concurrent acute brain infarctions in unselected patients with RAO and AF. Methods: A total of 213 consecutive patients with BRAO (20.7%), CRAO (47.4%), or AF (31.9%) were retrospectively studied from 2008 to 2013. Magnetic resonance imaging (MRI) was used to detect acute brain infarctions and a cardiovascular workup was performed to detect underlying etiologies according to the Trial of Org 10172 in Acute Stroke Management (TOAST). Results: MRI was obtained after 23.78 (±32.26) hours from the time of symptom onset. Acute brain infarctions were detected in 49 patients (23%); 44 of them (89.8%) did not experience any additional neurological symptoms. Older age (p < 0.001/p < 0.001), hypertension (p = 0.01/p = 0.03), atrial fibrillation (p = 0.006/p = 0.03) and type of RAO (p = 0.02/p = 0.016) were associated with total/silent stroke, respectively. In multivariate analysis, only age and type of occlusion remained positive predictors for silent stroke. Etiology of BRAO/CRAO and AF remained undetermined in 124 patients (58.2%). This rate was lower in patients with acute stroke (40.8 vs. 63.4%). Conclusions: Silent brain infarction is a frequent finding in unselected patients with BRAO/CRAO and AF. Etiology remains undetermined in approximately every second case. Because silent brain infarctions bear a high risk of future stroke, patients with BRAO/CRAO and AF should undergo prompt neuroimaging and cardiovascular checkup, preferably on a stroke unit.

Keywords:
Acute stroke, Retina, Magnetic resonance imaging
1.
Hayreh SS: Acute retinal arterial occlusive disorders. Prog Retin Eye Res 2011;30:359-394.
2.
Easton JD, Saver JL, Albers GW, et al: Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American academy of neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276-2293.
3.
Pollanen MS: Behaviour of suspended particles at bifurcations: implications for embolism. Phys Med Biol 1991;36:397-401.
4.
Lee J, Kim SW, Lee SC, et al: Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study. Am J Ophthalmol 2014;157:1231-1238.
5.
Helenius J, Arsava EM, Goldstein JN, et al: Concurrent acute brain infarcts in patients with monocular visual loss. Ann Neurol 2012;72:286-293.
6.
Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870.
7.
Arning C, Widder B, von Reutern GM, et al: [Revision of DEGUM ultrasound criteria for grading internal carotid artery stenoses and transfer to NASCET measurement]. Ultraschall Med 2010;31:251-257.
8.
MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991;337:1235-1243.
9.
Rothwell PM, Gibson RJ, Slattery J, et al: Equivalence of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists' Collaborative Group. Stroke 1994;25:2435-2439.
10.
Eastwood JD, Engelter ST, MacFall JF, et al: Quantitative assessment of the time course of infarct signal intensity on diffusion-weighted images. AJNR Am J Neuroradiol 2003;24:680-687.
11.
Copen WA, Schwamm LH, González RG, et al: Ischemic stroke: effects of etiology and patient age on the time course of the core apparent diffusion coefficient. Radiology 2001;221:27-34.
12.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
13.
Dion F, Saudeau D, Bonnaud I, et al: Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J Interv Card Electrophysiol 2010;28:101-107.
14.
Etgen T, Hochreiter M, Mundel M, et al: Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report. Stroke 2013;44:2007-2009.
15.
Cotter PE, Martin PJ, Ring L, et al: Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013;80:1546-1550.
16.
Sanna T, Diener HC, Passman RS, et al: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478-2486.
17.
Vermeer SE, Longstreth WT Jr, Koudstaal PJ: Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-619.
18.
Bokura H, Kobayashi S, Yamaguchi S, et al: Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 2006;15:57-63.
19.
Wright CB, Festa JR, Paik MC, et al: White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008;39:800-805.
20.
Wu RH, Li Q, Tan Y, et al: Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors. Neurol Sci 2014;35:1553-1559.
21.
Atkins EJ, Bruce BB, Newman NJ, et al: Translation of clinical studies to clinical practice: survey on the treatment of central retinal artery occlusion. Am J Ophthalmol 2009;148:172-173.
22.
Babikian V, Wijman CA, Koleini B, et al: Retinal ischemia and embolism. Etiologies and outcomes based on a prospective study. Cerebrovasc Dis 2001;12:108-113.
23.
Fonseca AC, Ferro JM: Cryptogenic stroke. Eur J Neurol 2015;22:618-623.
24.
Bang OY, Ovbiagele B, Kim JS: Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke 2014;45:1186-1194.
25.
Rudkin AK, Lee AW, Chen CS: Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 2009;16:674-677.
26.
Sposato LA, Cipriano LE, Saposnik G, et al: Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015;14:377-387.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.